Hangzhou Tigermed Consulting Co., Ltd. (3347.HK) HKSE

41.70

+1.06(+2.61%)

Updated at December 24 12:08PM

Currency In HKD

Valuation

Market Cap25.02B
Enterprise Value25.6B
P/E Ratio77.42
PEG Ratio0.73
Price/Sales Ratio6.19
Price/Book Ratio2.24
Enterprise/Revenue6.21
Enterprise/EBITDA31.93

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.09
Operating Margin0.03

Management Effectiveness

Return On Assets0.02
Return On Equity0.03

Income Statement

Revenue6.6B
Revenue/Share7.62
Gross Profit2.24B
EBITDA1.13B
Net Income405.14M
Diluted EPS0.47

Balance Sheet

Total Cash1.86B
Total Cash/Share1.98
Total Debt1.91B
Total Debt/Equity0.08
Current Ratio2.16
Book Value Per Share28.7

Price History

52-Week Change33.23
52-Week High60.6
52-Week Low22.3
Moving Average 50 Days41.43
Moving Average 200 Days40.58

Statistics

Average Volume2.03M
Shares Outstanding1.25B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.3
Trailing Annual Dividend Yield0.55
Payout Ratio0.5
Last Split FactorN/A
Last Split DateN/A